Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion.
Nicole M EhrhardtVanita R ArodaRodolfo J GalindoAnne L PetersJay H ShubrookPublished in: Clinical diabetes : a publication of the American Diabetes Association (2023)